27.09.2011 • News

Walgreen Q4 Profit Surges

Walgreen reported fourth-quarter net earnings of $792 million or $0.87 per share, compared with $470 million or $0.49 per share last year.

Excluding an after-tax gain of 30 cents per share associated with the company's sale of its pharmacy benefits management business, Walgreen posted earnings of $519 million or $0.57 per share in the latest quarter. On average, 17 analysts polled by Thomson Reuters expected earnings per share of $0.55 for the quarter. Analysts' estimates typically exclude one-time items.

Fourth quarter sales increased 6.5% to $17.97 billion from the prior-year quarter sales of $16.87 billion. Total sales in comparable stores grew 4.4% in the quarter, while front-end comparable drugstore sales increased 4.6% in the quarter. Sixteen analysts estimated revenues of $17.88 billion for the quarter.

Walgreens President and CEO Greg Wasson said, "We are confident that fiscal 2012 will be another great year of progress in our ongoing transformation and commitment to serving consumers and patients where they live and work."

Book

Innovation Management in Sustainable Chemistry

Innovation Management in Sustainable Chemistry

Comprehensive resource on sustainable chemistry, bridging the skill gap between academic science education and innovation and entrepreneurship

Free Virtual Event

Batteries and Hydrogen: Competitors or Partners?
CHEManager Spotlight

Batteries and Hydrogen: Competitors or Partners?

17 September 2026 | Reserve your spot to learn where solid-state batteries and green hydrogen are headed—and how leading teams are turning them into scalable energy storage solutions.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.